Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
出版年份 2014 全文链接
标题
Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
作者
关键词
-
出版物
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 12, Issue 37, Pages 7261-7269
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-08-07
DOI
10.1039/c4ob01550a
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
- (2014) Yilma T. Adem et al. BIOCONJUGATE CHEMISTRY
- Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
- (2013) Lourdes Castañeda et al. CHEMICAL COMMUNICATIONS
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Antibody-drug conjugates
- (2013) Alain Beck et al. mAbs
- A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones
- (2013) Lourdes Castañeda et al. TETRAHEDRON LETTERS
- Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
- (2013) Felix F. Schumacher et al. Scientific Reports
- Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-closo-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-closo-Decaborate(2-) Reagent via Lysine Amines
- (2012) D. Scott Wilbur et al. BIOCONJUGATE CHEMISTRY
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
- (2011) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
- (2011) Felix F. Schumacher et al. BIOCONJUGATE CHEMISTRY
- Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
- (2011) Chris P. Ryan et al. CHEMICAL COMMUNICATIONS
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- The development of pyrrolobenzodiazepines as antitumour agents
- (2011) John A Hartley EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
- (2011) Robert Y. Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analytical methods for physicochemical characterization of antibody drug conjugates
- (2011) Aditya Wakankar et al. mAbs
- Physicochemical Stability of the Antibody−Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
- (2010) Aditya A. Wakankar et al. BIOCONJUGATE CHEMISTRY
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Chemoenzymatic methods for site-specific protein modification
- (2010) David Rabuka CURRENT OPINION IN CHEMICAL BIOLOGY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate
- (2008) Svetlana O. Doronina et al. BIOCONJUGATE CHEMISTRY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started